After knowing the authorization of the vaccine against covid-19 developed by Oxford-AstraZeneca in the United Kingdom and Argentina, we present a comparative table with the vaccine from Pfizer-BioNtech.
Furthermore, Dr. Carlos del Río, from Emory University in Atlanta, explains why this authorization is good news for the Latin American region.